Bluejay Diagnostics, Inc. (BJDX) vs GlucoTrack, Inc. (GCTK)

A side-by-side comparison of Bluejay Diagnostics, Inc. and GlucoTrack, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bluejay Diagnostics, Inc. logo
BJDX
Bluejay Diagnostics, Inc.
$787624
$0.76HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GlucoTrack, Inc. logo
GCTK
GlucoTrack, Inc.
$885939
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BJDX vs GCTK

growth of $100 · dividends reinvested · last 5y
BJDX -100.0% (-91.5%/yr)GCTK -100.0% (-92.1%/yr)BJDX compounded faster over this window
020406080100Start $10020222023202420252026$0$0
BJDX GCTK

BJDX vs GCTK: by the numbers

  • •GCTK is the larger company ($885939 vs $787624 market cap).

Metrics side by side

Valuation

MetricBJDXGCTK
P/B ratio0.08N/A

Profitability

MetricBJDXGCTK
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-77.23%N/A
ROIC-77.55%N/A

Growth (annualized)

MetricBJDXGCTK
Total return CAGR (5Y)N/A-92.60%

Go deeper

Full BJDX analysisFull GCTK analysisInteractive comparison tool

Dig into the metrics

Bluejay Diagnostics ROEGlucoTrack ROEBluejay Diagnostics operating marginGlucoTrack operating marginBluejay Diagnostics revenue growthGlucoTrack revenue growthBluejay Diagnostics free cash flowGlucoTrack free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.